Each therapeutic area carries its own nuanced challenges for drug discovery. Eurofins Discovery scientists’ deep experience across a broad range of diseases will guide you to the most appropriate assays based on your therapeutic area of focus or target class of interest.
Our teams stay at the forefront of therapeutic knowledge so they can generate the most actionable data for your research. Our cross-disciplinary expertise enables us to work efficiently with fast turnaround times—without compromising quality.
A high number of diseases have unmet therapeutic needs, including cancer, inflammatory diseases, infectious diseases, neurodegenerative diseases, and other central nervous system (CNS) disorders. We can enhance your success in these and other areas through the development of clinically relevant assays that deliver robust insights. Our industry-leading track record shows we can bridge the translational gap between discovery and the clinic with our ability to model human disease by employing a variety of leading edge technologies.
Our scientists have the depth of knowledge and access to a global infrastructure that provides for efficient communication with your team. Our project managers and study directors keep you informed of your program’s progress to address challenges before they become problems. Find your therapeutic area of interest below and discover more about how we can help.
Key Areas
Cardiovascular Disease
Advance your cardiovascular disease program with our extensive offerings that include iPSC-derived cardiomyocytes, translational biology profiling, CiPA panels, in vitro target-based assays and in vivo rodent models.
MASH and Diabetes Drug Discovery
Advancing MASH and diabetes drug development by comprehensively characterizing drug candidates through in vitro specialized panels and in vivo animal models
Fibrosis
Accelerate the development of fibrosis therapies – from early discovery to clinical success - using validated translational human primary cell and animal models and our unmatched portfolio of in vitro assays.
Infectious Diseases
Identify novel anti-infective agents with more than 100 validated, clinically relevant infection models and 850+ MIC characterized strains and MDR clinical isolates.
Inflammation
Reveal anti-inflammatory properties of potential therapies by taking advantage of our disease-relevant in vitro and in vivo models and our unique systems biology approach to provide insights on mechanism of action.
Immunology
Fast track your projects using our human-centric in vitro assays and physiological models to assess the impact of drug candidates on immune-related biomarkers.
Metabolic Disorders
Leverage our broad portfolio of disease-specific in vivo models and in vitro panels to propel your metabolic disorder programs forward.
Neuroscience
Explore new frontiers with our leading portfolio of in vivo models, target-based screening and profiling capacities, and dedicated panels for pain and neurodegenerative diseases.
Oncology and Immuno-Oncology
Unlock the door to new therapeutic strategies for oncology and immuno-oncology with our best-in-class cellular, target-based and genomic profiling services and in vivo efficacy models.
Orphan Diseases
Unravel the mysteries of orphan and rare diseases from target identification through to your preclinical candidate via our comprehensive portfolio of assays and models.
Renal Disorders
Uncover novel mechanisms for renal disorders with our drug transporter panels, cell proliferation assays, and safety and toxicology testing.
Respiratory Diseases
Gain new insight into respiratory diseases like COVID-19 using our SARS-CoV-2 spike S1-ACE2 binding assay and expanded portfolio of in vitro assays and Translational Biology models.
Questions? Contact Us
You can easily get in touch with a Eurofins Discovery Expert or get help from our Customer Service team. Reach out with questions, or to discuss your specific discovery challenges.
